Question explored with the scientific record
depomedrol
Depo-Medrol is a steroid injection that can help pain short-term, but it suppresses your adrenal glands and can slow a child's growth, and the long-term safety data is thin.
Depo-Medrol (methylprednisolone acetate) is a long-acting corticosteroid. The retrieved evidence shows it works for some conditions. In De Quervain's tenosynovitis, about 81 in 100 patients had complete relief at 6 weeks after one injection, though 30 in 100 later relapsed [3]. For adhesive capsulitis (frozen shoulder), steroid injection gave faster pain relief and movement at 2 weeks than placebo, but by 12 weeks there was no difference between groups [6]. A second injection added nothing over the first [7]. For acute asthma, one intramuscular shot prevented relapse better than a tapering oral course in a small 1988 study [2].
The harms are real and often understated. One 60 mg injection in children with hay fever measurably slowed lower-leg growth during the pollen season; the study did not track final adult height [4]. Epidural injections of 80 mg suppressed adrenal function in about 86 in 100 adults at one week, with gradual recovery over four weeks [5]. Even 40 mg suppressed it in about half [5]. That means your body's stress response is temporarily shut off, which matters if you get sick or injured.
The evidence base is narrow. Most studies are small, short-term, and measure symptoms, not long-term outcomes. No retrieved study followed patients for years to check for bone loss, diabetes, or adrenal failure. The 2013 contaminated-injection outbreak, where 21 in 100 screened patients had abnormal MRIs, is a reminder that injectable steroids carry infection risk [1].
My call: Depo-Medrol offers real but temporary symptom relief, at the cost of measurable adrenal suppression and growth slowing in children. Use it only when the pain is severe and short-term, and never repeatedly. Confidence: moderate.
Sources used 7
-
Magnetic Resonance Imaging Screening to Identify Spinal and Paraspinal Infections Associated With Injections of Contaminated Methylprednisolone Acetate
This study investigates the use of magnetic resonance imaging (MRI) screening to identify spinal and paraspinal infections in patients who received contaminated methylprednisolone injections, revealing that 21% of screened patients had abnormal MRIs indicative of infection, lead…
DOI: 10.1001/jama.2013.6293 -
Oral vs Repository Corticosteroid Therapy in Acute Asthma
This study compares the effectiveness of a single intramuscular injection of repository corticosteroid (methylprednisolone sodium acetate) to a tapering course of oral corticosteroids in treating acute asthma, finding that the former may be more effective in preventing relapse a…
DOI: 10.1378/chest.93.1.11 -
Treatment of de Quervain's tenosynovitis with corticosteroids. A prospective study of the response to local injection
This study evaluates the effectiveness of methylprednisolone acetate injections in treating De Quervain's tenosynovitis, finding that approximately 90% of patients experienced significant symptom relief, with minimal adverse reactions.
DOI: 10.1002/art.1780340703 -
Short‐term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids
In children with allergic rhinitis, depot methylprednisolone acetate 60 mg and intranasal budesonide 400 µg/day reduced knemometric lower leg growth velocity during the grass pollen season, while oral terfenadine 60 mg/day did not; long-term statural growth was not assessed.
DOI: 10.1111/j.1651-2227.1993.tb18030.x -
The effect of epidural methylprednisolone acetate injection on the hypothalamic-pituitary-adrenal axis
A randomized, single-blind clinical trial comparing 80 mg versus 40 mg epidural methylprednisolone acetate in adults with radicular low back pain found substantial early HPA-axis suppression, greater early pain relief with the higher dose, and gradual adrenal recovery over four …
DOI: 10.1016/j.jclinane.2013.07.002 -
Effectiveness of corticosteroid injection in adhesive capsulitis
A randomized controlled trial in Turkey comparing intraarticular corticosteroid injection plus a 12‑week home exercise program versus placebo injection plus the same program in adhesive capsulitis found rapid short‑term pain relief and range‑of‑motion gains with steroids, but no…
DOI: 10.1177/0269215508086179 -
Intraarticular corticosteroid injection in adhesive capsulitis: are two doses better than a single dose? a randomized prospective study
Two intraarticular corticosteroid injections did not significantly improve 12-week range-of-motion or shoulder pain/disability outcomes compared with a single injection in adhesive capsulitis.
DOI: 10.18203/issn.2455-4510.intjresorthop20163123